Adenosine 5′ -Triphosphate Disodium Salt (ATP) CAS No. 987-65-5
Product Description
Adenosine Triphosphate Disodium(ATP) is a kind of coenzyme, to improve the role of metabolism involved in body fat, protein, sugar, nucleic acid and the metabolism of nucleotides. At the same time is the main source of energy in the body, when in vivo absorption, secretion, muscle contraction and synthesis of biochemical reactions necessary energies, that is decomposed into adenosine triphosphate, adenosine diphosphate and phosphate-based, also release energy. Animal testing to prove product can inhibit the slow response to the slow fibers in calcium influx, block or delay the atrioventricular conduction pathway forward, large doses may also block or delay the bypass forward and reverse conduction; other also has a strong short-term enhancement of the role of the vagus nerve, which can terminate AV nodal reentrant and mechanism bypass caused reentry arrhythmia.
| Product Name: | Adenosine 5'-triphosphate disodium salt |
| CAS: | 987-65-5 |
| MF: | C10H17N5NaO13P3 |
| MW: | 531.18 |
| EINECS: | 213-579-1 |
Function and Application
1. Clinically used for tissue damage, cell enzyme activity decline caused by various diseases.Such as heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary atherosclerosis, progressive muscle atrophy, cerebral hemorrhage sequelae, acute or chronic hepatitis, cirrhosis and hearing impairment, etc.
2. Adenosine triphosphate disodium is coenzyme drugs, used in progressive muscular dystrophy, cerebral apoplexy sequelae, cardiac insufficiency, myocardial disease, hepatitis treatment, etc.Clinically used for tissue damage, cell enzyme activity decline caused by various diseases.Such as heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary atherosclerosis, progressive muscle atrophy, cerebral hemorrhage sequelae, acute or chronic hepatitis, cirrhosis and hearing impairment, etc.
3. Adenosine triphosphate disodium is coenzyme drugs, used in progressive muscular dystrophy, cerebral apoplexy sequelae, cardiac insufficiency, myocardial disease, hepatitis treatment, etc.
